References
- 1. Przyklenk, K., & Kloner, R. A. (1998). Ischemic preconditioning: exploring the paradox. Prog Cardiovasc Dis, 40(6), 517-547.10.1016/S0033-0620(98)80002-9
- 2. Ara, J., Fekete, S., Frank, M., Golden, J. A., Pleasure, D., & Valencia, I. (2011). Hypoxic-preconditioning induces neuroprotection against hypoxia-ischemia in newborn piglet brain. Neurobiol Dis, 43(2), 473-485.10.1016/j.nbd.2011.04.021
- 3. Cantagrel, S., Krier, C., Ducrocq, S., Bodard, S., Payen, V., Laugier, J., Chalon, S. (2003). Hypoxic preconditioning reduces apoptosis in a rat model of immature brain hypoxia-ischaemia. Neurosci Lett, 347(2), 106-110.
- 4. Altug, S., Demiryurek, A. T., Kane, K. A., & Kanzik, I. (2000). Evidence for the involvement of peroxynitrite in ischaemic preconditioning in rat isolated hearts. Br J Pharmacol, 130(1), 125-131.
- 5. Verma, S., Maitland, A., Weisel, R. D., Li, S. H., Fedak, P. W., Pomroy, N. C., Rao, V. (2002). Hyperglycemia exaggerates ischemia-reperfusion-induced cardiomyocyte injury: reversal with endothelin antagonism. J Thorac Cardiovasc Surg, 123(6), 1120-1124.
- 6. Yellon, D. M., & Hausenloy, D. J. (2007). Myocardial reperfusion injury. N Engl J Med, 357(11), 1121-1135.
- 7. Gomes, O. M., Magalhaes Mde, M., & Abrantes, R. D. (2010). Myocardium functional recovery protection by omeprazole after ischemia-reperfusion in isolated rat hearts. Rev Bras Cir Cardiovasc, 25(3), 388-392.
- 8. Gomes, O. M., Magalhaes Mde, M., Abrantes, R. D., & Kallas, E. (2011). Pantoprazole provides myocardial protection similar to ischemic preconditioning: experimental study of isolated hearts of rats. Rev Bras Cir Cardiovasc, 26(3), 433-439.
- 9. Jeremic, N., Petkovic, A., Srejovic, I., Zivkovic, V., Djuric, D., & Jakovljevic, V. (2015). Effects of ischemia and omeprazole preconditioning on functional recovery of isolated rat heart. Rev Bras Cir Cardiovasc, 30(2), 266-275.
- 10. Ohkawa, H., Ohishi, N., & Yagi, K. (1979). Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem, 95(2), 351-358.
- 11. Green, L. C., Wagner, D. A., Glogowski, J., Skipper, P. L., Wishnok, J. S., & Tannenbaum, S. R. (1982). Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem, 126(1), 131-138.
- 12. C Auclair, E Voisin. (1985). Nitroblue tetrazolium reduction Vol. 123. Handbook of methods for oxygen radical research (pp. 123–132).
- 13. Pick, E., & Keisari, Y. (1980). A simple colorimetric method for the measurement of hydrogen peroxide produced by cells in culture. J Immunol Methods, 38(1-2), 161-170.10.1016/0022-1759(80)90340-3
- 14. Goswami, S. K., Maulik, N., & Das, D. K. (2007). Ischemia-reperfusion and cardioprotection: a delicate balance between reactive oxygen species generation and redox homeostasis. Ann Med, 39(4), 275-289.10.1080/07853890701374677
- 15. Kurzelewski, M., Czarnowska, E., & Beresewicz, A. (2005). Superoxide- and nitric oxide-derived species mediate endothelial dysfunction, endothelial glycocalyx disruption, and enhanced neutrophil adhesion in the post-ischemic guinea-pig heart. J Physiol Pharmacol, 56(2), 163-178.
- 16. Raedschelders, K., Ansley, D. M., & Chen, D. D. (2012). The cellular and molecular origin of reactive oxygen species generation during myocardial ischemia and reperfusion. Pharmacol Ther, 133(2), 230-255.
- 17. Nonami, Y. (1997). The role of nitric oxide in cardiac ischemia-reperfusion injury. Jpn Circ J, 61(2), 119-132.10.1253/jcj.61.119
- 18. Hess, M. L., & Manson, N. H. (1984). Molecular oxygen: friend and foe. The role of the oxygen free radical system in the calcium paradox, the oxygen paradox and ischemia/reperfusion injury. J Mol Cell Cardiol, 16(11), 969-985.
- 19. Pagliaro, P., & Penna, C. (2015). Redox signalling and cardioprotection: translatability and mechanism. Br J Pharmacol, 172(8), 1974-1995.
- 20. Wandall, J. H. (1992). Effects of omeprazole on neutrophil chemotaxis, super oxide production, degranulation, and translocation of cytochrome b-245. Gut, 33(5), 617-621.
- 21. Hackert, T., Tudor, S., Felix, K., Dovshanskiy, D., Hartwig, W., Simon, W. A., & Werner, J. (2010). Effects of pantoprazole in experimental acute pancreatitis. Life Sci, 87(17-18), 551-557.
- 22. Simon, W. A., Sturm, E., Hartmann, H. J., & Weser, U. (2006). Hydroxyl radical scavenging reactivity of proton pump inhibitors. Biochem Pharmacol, 71(9), 1337-1341.
- 23. Biswas, K., Bandyopadhyay, U., Chattopadhyay, I., Varadaraj, A., Ali, E., & Banerjee, R. K. (2003). A novel antioxidant and antiapoptotic role of omeprazole to block gastric ulcer through scavenging of hydroxyl radical. J Biol Chem, 278(13), 10993-11001.
- 24. Gozal, Y., Chevion, M., Elami, A., Berenshtein, E., Kitrossky, N., & Drenger, B. (2005). Ischaemic preconditioning but not isoflurane prevents post-ischaemic production of hydroxyl radicals in a canine model of ischaemia-reperfusion. Eur J Anaesthesiol, 22(1), 49-55.
- 25. Doucet, A. (1997). H+, K(+)-ATPASE in the kidney: localization and function in the nephron. Exp Nephrol, 5(4), 271-276.
- 26. Hayashi, H., Shimamoto, K., Taniai, E., Ishii, Y., Morita, R., Suzuki, K., Mitsumori, K. (2012). Liver tumor promoting effect of omeprazole in rats and its possible mechanism of action. J Toxicol Sci, 37(3), 491-501.10.2131/jts.37.491
- 27. Petronilho, F., Araujo, J. H., Steckert, A. V., Rezin, G. T., Ferreira, G. K., Roesler, R., Streck, E. L. (2009). Effect of a gastrin-releasing peptide receptor antagonist and a proton pump inhibitor association in an animal model of gastritis. Peptides, 30(8), 1460-1465.